Q3 2026 13F filing
Updated 9 days ago50 disclosed positions worth $908.7M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P Praxis Precision Medicines | $79M | 271.1K | 8.69% | — |
| 2 | T Trevi Therapeutics Inc | $60.6M | 4.23M | 6.67% | — |
| 3 | E Erasca Inc | $58.9M | 4.02M | 6.49% | — |
| 4 | A Arrivent BioPharma Inc | $54.1M | 1.79M | 5.96% | — |
| 5 | A Abivax SA | $41.1M | 414.9K | 4.52% | — |
| 6 | E Entera Bio Ltd | $35.7M | 12.25M | 3.92% | — |
| 7 | A Aclaris Therapeutics Inc | $35.2M | 6.69M | 3.88% | — |
| 8 | A Alto Neuroscience Inc | $34.7M | 1.36M | 3.82% | — |
| 9 | T Tango Therapeutics Inc | $34.4M | 1.38M | 3.79% | — |
| 10 | C Corvus Pharmaceuticals Inc | $32.3M | 2.81M | 3.56% | — |
| 11 | L LB Pharmaceuticals Inc | $30.7M | 800.0K | 3.38% | — |
| 12 | K Korsana Biosciences Inc | $28.1M | 877.0K | 3.09% | — |
| 13 | ? N/A Blossomhill Therapeutics Inc | $27.8M | 1.49M | 3.06% | — |
| 14 | F Faeth Therapeutics Inc | $25.1M | 844.6K | 2.76% | — |
| 15 | C CAMP4 Therapeutics Corporation | $22.6M | 5.58M | 2.48% | — |
| 16 | A Achieve Life Science Inc | $22.3M | 2.75M | 2.45% | — |
| 17 | S SAB Biotherapeutics Inc | $21.9M | 6.92M | 2.41% | — |
| 18 | D DBV Technologies SA | $21.7M | 1.84M | 2.39% | — |
| 19 | D Bright Minds Biosciences Inc | $20.8M | 417.9K | 2.29% | — |
| 20 | D Design Therapeutics Inc | $20.3M | 1.61M | 2.23% | — |
| 21 | ? N/A AN2 Therapeutics Inc | $16.8M | 3.15M | 1.85% | — |
| 22 | M Moonlake Immunotherapeutics | $16.4M | 1.40M | 1.80% | — |
| 23 | N Minerva Neurosciences Inc | $14.5M | 4.32M | 1.59% | — |
| 24 | O Odyssey Therapeutics Inc | $12.8M | 575.0K | 1.41% | — |
| 25 | O Oric Pharmaceuticals Inc | $12.5M | 924.4K | 1.37% | — |
| 26 | E Eupraxia Pharmaceuticals Inc | $12.3M | 1.35M | 1.35% | — |
| 27 | V Vor Biopharma Inc | $10.5M | 550.4K | 1.16% | — |
| 28 | E Editas Medicine Inc | $9.1M | 3.56M | 1.01% | — |
| 29 | ? N/A Surrozen Inc | $8.4M | 260.0K | 0.92% | — |
| 30 | D Dyne Therapeutics Inc | $8.3M | 514.4K | 0.91% | — |
| 31 | A Aura Biosciences Inc | $7.3M | 1.17M | 0.81% | — |
| 32 | ? N/A Cue Biopharma Inc | $7.2M | 280.1K | 0.80% | — |
| 33 | M Monopar Therapeutics Inc | $7.2M | 90.5K | 0.79% | — |
| 34 | M Satellos Bioscience Inc | $6.9M | 813.7K | 0.76% | — |
| 35 | O Olema Pharmaceuticals Inc | $5.8M | 671.8K | 0.64% | — |
| 36 | P Pepgen Inc | $5.6M | 2.33M | 0.62% | — |
| 37 | O Onkure Therapeutics Inc | $5.3M | 1.93M | 0.58% | — |
| 38 | ? N/A Attovia Therapeutics Inc | $5.1M | 300.0K | 0.57% | — |
| 39 | A ADARx Pharmaceuticals Inc | $5.1M | 255.2K | 0.56% | — |
| 40 | T Tenax Therapeutics Inc | $4.7M | 2.50M | 0.52% | — |
| 41 | V Valneva SE | $4.7M | 763.2K | 0.52% | — |
| 42 | A Avalo Therapeutics Inc | $4.2M | 275.0K | 0.46% | — |
| 43 | ? N/A Compass Therapeutics Inc | $3.6M | 3.42M | 0.39% | — |
| 44 | S Sera Prognostics Inc | $3.4M | 1.65M | 0.38% | — |
| 45 | T Instil Bio Inc | $2.1M | 292.7K | 0.23% | — |
| 46 | I InMed Pharmaceuticals Inc | $1.1M | 824.9K | 0.12% | — |
| 47 | ? N/A Bolt Biotherapeutics Inc | $266K | 72.4K | 0.03% | — |
| 48 | K Pasithea Therapeutics Corp | $184K | 372.8K | 0.02% | — |
| 49 | D Precision Biosciences Inc | $29K | 4.7K | 0.00% | — |
| 50 | J Jasper Therapeutics Inc | $4K | 5.4K | 0.00% | — |